Testagen
Lys-Glu-Asp-Gly (KEDG)
Testagen is a synthetic tetrapeptide with laboratory findings on uptake of labeled peptides and nucleic-acid interactions.
Peptipedia explains research and prescribing information. It does not replace medical advice and is not an invitation to use a substance.
Research areas
Evidence matrix
- Molecular identity
- Confirmed
The cited primary study defines Testagen as Lys-Glu-Asp-Gly. This assignment does not confirm product purity, salt form or a commercial lot.
- Human research
- None
- Replication
- Single research group
- Clinical endpoints
- No clinical endpoints
- Safety
- Not adequately studied
- Approval
- No documented approval
The dimensions are presented separately and are not combined into an overall score.
What the source shows
Experiments occurred in cell culture and cell-free binding systems, not as treatment of living people.
- Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNALaboratory study2011
Fedoreyeva LI et al.
Accessed:
Research gaps
- ·This does not establish a clinical testosterone increase or reproductive benefit. Independent replication and human studies are absent.
- ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.
Mechanism
The study examined fluorescently labeled peptides in HeLa cells and DNA-binding assays; it did not demonstrate gene regulation in humans.
- Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNALaboratory study2011
Fedoreyeva LI et al.
Accessed:
Study protocols
No sufficiently supported, exactly citable study protocols are available.
Calculator
Arithmetic based only on your entries. Not a dose or use recommendation.
Reported adverse effects
- ·Evidence is insufficient; absence of data is not evidence of safety. Human exposure, toxicology, contraindications and interactions have not been adequately studied.
Contraindications and warnings
No reviewed information on this point has been recorded here yet. This does not mean there are no risks or contraindications.
Interactions
No reviewed information on this point has been recorded here yet. This does not mean there are no risks or contraindications.
Research gaps
- ·This does not establish a clinical testosterone increase or reproductive benefit. Independent replication and human studies are absent.
- ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.
- Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNALaboratory study2011
Fedoreyeva LI et al.
Accessed:
Sources
Sources checked: · Version 3
- Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNALaboratory study2011
Fedoreyeva LI et al.
Accessed: